2006
DOI: 10.1016/j.ydbio.2006.03.050
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitor-resistant type I receptors reveal specific requirements for TGF-β signaling in vivo

Abstract: Activin/nodal-like TGF-beta superfamily ligands signal through the type I receptors Alk4, Alk5, and Alk7, and are responsible for mediating a number of essential processes in development. SB-431542, a chemical inhibitor of activin/nodal signaling, acts by specifically interfering with type I receptors. Here, we use inhibitor-resistant mutant receptors to examine the efficacy and specificity of SB-431542 in Xenopus and zebrafish embryos. Treatment with SB-431542 eliminates Smad2 phosphorylation in vivo and gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
48
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(53 citation statements)
references
References 41 publications
4
48
1
Order By: Relevance
“…The phosphorylation of Smad2 was observed to be inhibited in embryos treated with the type I receptor kinase inhibitor SB-431542 (Muèllera et al 1999;Ho et al 2006). This inhibitor did not affect the expression of HSC70.…”
Section: -1 Control Of Tgf-β β β β β Receptor Activationmentioning
confidence: 91%
“…The phosphorylation of Smad2 was observed to be inhibited in embryos treated with the type I receptor kinase inhibitor SB-431542 (Muèllera et al 1999;Ho et al 2006). This inhibitor did not affect the expression of HSC70.…”
Section: -1 Control Of Tgf-β β β β β Receptor Activationmentioning
confidence: 91%
“…In amphibians, these genes are zygotically expressed under the control of the maternal T-box transcription factor Vegt (Heasman, 2006). Inhibition of Nodal signaling in Xenopus via the overexpression of Nodal antagonists or by treatment with small-molecule Nodal receptor inhibitors leads to gastrulation defects (Agius et al, 2000;Ho et al, 2006;Osada and Wright, 1999;Sun et al, 1999). Three other Smad2/3-activating TGFβs function during mesendoderm formation: Gdf1/Vg1 is maternal, while Gdf3/Derriere and Inhbb/ ActivinβB are zygotic.…”
Section: Introductionmentioning
confidence: 99%
“…We used the low molecular weight inhibitor SB431542 (Alk5/4-i), which specifically blocks TGF/Activin pathway receptors and does not affect closely related receptors from the bone morphogenetic protein (BMP) pathway or other signal transduction pathways (Ho et al, 2006;Inman et al, 2002;Jazwinska et al, 2007). The mechanism of this selectivity has recently been determined by solving the crystal structure of the mammalian TGF type I receptor kinase domain in complex with SB431542 (Ogunjimi et al, 2012).…”
mentioning
confidence: 99%